Together, the results suggest that the model in Fig. 5e operates in breast cancer cell lines, where stimulation of the TRAIL/DR5 pathway activates caspases that execute cell death in part through decreased expression of elements of the HER/PI3K/PDK1/Akt survival pathway. Here, TNFRSF10B is linked to breast carcinoma.